Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Shen, Miao ^a   Lu, Jie ^a   Dai, Weiqi ^a   Wang, Fan ^a   Xu, Ling ^a   Chen, Kan ^a   He, Lei ^a   Cheng, Ping ^a   Zhang, Yan ^a   Wang, Chengfen ^a   Wu, Dong ^a   Yang, Jing ^a   Zhu, Rong ^a   Zhang, Huawei ^a   Zhou, Yinqun ^a   Guo, Chuanyong ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; BECLIN 1; COMPLEMENTARY DNA; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B KINASE BETA; INTERLEUKIN 6; LIVER ENZYME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN LC3; PYRUVIC ACID ETHYL ESTER; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, MOUSE; BECN1 PROTEIN, MOUSE; HMGB1 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; PYRUVIC ACID DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPHAGY; CELL DEATH; CELL INFILTRATION; CELL ULTRASTRUCTURE; DOSE RESPONSE; DRUG EFFECT; ELECTRON MICROSCOPY; EXPERIMENTAL DESIGN; HEPATIC WARM ISCHEMIA; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIVER ISCHEMIA; LIVER NECROSIS; MALE; MOUSE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DRUG ANTAGONISM; METABOLISM;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BCL-2-ASSOCIATED X PROTEIN; HMGB1 PROTEIN; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRUVATES; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896321924     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/461536     Document Type: Article

References (49)

1. Theodoraki K., Tympa A., Karmaniolou I., Tsaroucha A., Arkadopoulos N., Smyrniotis V., Ischemia/reperfusion injury in liver resection: a review of preconditioning methods. Surgery Today 2011 41 5 620 629 2-s2.0-79956213765 10.1007/s00595-010-4444-4
2. Abu-Amara M., Yang S. Y., Tapuria N., Fuller B., Davidson B., Seifalian A., Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transplantation 2010 16 9 1016 1032 2-s2.0-77956897433 10.1002/lt.22117
3. Czubkowski P., Socha P., PawŁowska J., Oxidative stress in liver transplant recipients. Annals of Transplantation 2011 16 1 99 108 2-s2.0-79953272568
4. Siriussawakul A., Zaky A., Lang J. D., Role of nitric oxide in hepatic ischemia-reperfusion injury. World Journal of Gastroenterology 2010 16 48 6079 6086 2-s2.0-78650774842 10.3748/wjg.v16.i48.6079
5. van Golen R. F., van Gulik T. M., Heger M., The sterile immune response during hepatic ischemia/reperfusion. Cytokine & Growth Factor Reviews 2012 23 3 69 84 10.1016/j.cytogfr.2012.04.006
6. Pan S., Liu L., Jiang H., Protective effects of hydroxytyrosol on liver ischemia/reperfusion injury in mice. Molecular Nutrition & Food Research 2013 57 7 1218 1227 10.1002/mnfr.201300010
7. Elias-Miro M., Jimenez-Castro M. B., Peralta C., Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radical Research 2013 47 8 555 568 10.3109/10715762.2013.811721
8. Guicciardi M. E., Malhi H., Gores G. J., Apoptosis and necrosis in the liver. Comprehensive Physiology 2013 3 2 977 1010
9. Georgiev P., Dahm F., Graf R., Clavien P.-A., Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver. Current Pharmaceutical Design 2006 12 23 2911 2921 2-s2.0-33746901108 10.2174/138161206777947588 (Pubitemid 44184625)
10. Weigand K., Brost S., Steinebrunner N., Büchler M., Schemmer P., Müller M., Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surgery 2012 2012 8 10.1155/2012/176723 176723
11. Ozaki M., Haga S., Ozawa T., In vivo monitoring of liver damage using caspase-3 probe. Theranostics 2012 2 2 207 214 10.7150/thno.3806
12. Kim S. J., Eum H. A., Lee S. M., Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Shock 2013 39 4 380 388 10.1097/SHK.0b013e31828aab7f
13. Lin H. C., Lai I. R., Isolated mitochondria infusion mitigates ischemia-reperfusion injury of the liver in rats. Shock 2013 39 3 304 310 10.1097/SHK.0b013e318283035f
14. Neuman M. G., Apoptosis in diseases of the liver. Critical Reviews in Clinical Laboratory Sciences 2001 38 2 109 166 10.1080/20014091084182 (Pubitemid 32391858)
15. Deniaud A., Hoebeke J., Briand J.-P., Muller S., Jacotot E., Brenner C., Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction. Current Pharmaceutical Design 2006 12 34 4501 4511 2-s2.0-33751543499 10.2174/138161206779010530 (Pubitemid 44835159)
16. Choi A. M., Ryter S. W., Levine B., Autophagy in human health and disease. The New England Journal of Medicine 2013 368 7 651 662 10.1056/NEJMra1205406
17. Maiuri M. C., Grassia G., Platt A. M., Carnuccio R., Ialenti A., Maffia P., Macrophage autophagy in atherosclerosis. Mediators of Inflammation 2013 2013 14 10.1155/2013/584715 584715
18. Kaushal G. P., Autophagy protects proximal tubular cells from injury and apoptosis. Kidney International 2012 82 12 1250 1253 10.1038/ki.2012.337
19. Zhang X., Yan H., Yuan Y., Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 2013 9 9 1321 1333 10.4161/auto.25132
20. Rautou P.-E., Mansouri A., Lebrec D., Durand F., Valla D., Moreau R., Autophagy in liver diseases. Journal of Hepatology 2010 53 6 1123 1134 2-s2.0-78049486018 10.1016/j.jhep.2010.07.006
21. Dong Y., Undyala V. V., Gottlieb R. A., Mentzer R. M. Jr., Przyklenk K., Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics 2010 15 3 220 230 2-s2.0-77956843184 10.1177/1074248410370327
22. Zhou X. J., Zhang H., in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy 2012 8 9 1286 1299 10.4161/auto.21212
23. Wang D., Ma Y., Jiang H., The role of AKT1 and in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice. Autophagy 2012 8 6 954 962 10.4161/auto.19927
24. Cardinal J., Pan P., Dhupar R., Ross M., Nakao A., Lotze M., Billiar T., Geller D., Tsung A., Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology 2009 50 2 565 574 2-s2.0-68949194361 10.1002/hep.23021
25. Zhou Y., Dai W., Guo C., Protective effects of necrostain-1 in concanavalin A-induced acute hepatic injury in mice. Mediators Inflammation 2013 2013 706156
26. Kang R., Zeh H. J., Lotze M. T., Tang D., The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation 2011 18 4 571 580 2-s2.0-79952628267 10.1038/cdd.2010.191
27. Wong P. M., Puente C., Jiang X., The ULK1 complex: sensing nutrient signals for autophagy activation. Autophagy 2013 9 2 124 137 10.4161/auto.23323
28. Shanware N. P., Bray K., Abraham R. T., The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease. Annual Review of Pharmacology and Toxicology 2013 53 89 106 10.1146/annurev-pharmtox- 010611-134717
29. Gujral J. S., Bucci T. J., Farhood A., Jaeschke H., Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001 33 2 397 405 2-s2.0-0035140552 10.1053/jhep.2001.22002 (Pubitemid 32119028)
30. Cursio R., Colosetti P., Saint-Paul M.-C., Pagnotta S., Gounon P., Iannelli A., Auberger P., Gugenheim J., Induction of different types of cell death after normothermic liver ischemia-reperfusion. Transplantation Proceedings 2010 42 10 3977 3980 2-s2.0-78650474022 10.1016/j.transproceed.2010.09.140
31. Lemasters J. J., Nieminen A.-L., Qian T., Trost L. C., Elmore S. P., Nishimura Y., Crowe R. A., Cascio W. E., Bradham C. A., Brenner D. A., Herman B., The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochimica et Biophysica Acta 1998 1366 1-2 177 196 2-s2.0-0032504568 10.1016/S0005-2728(98)00112-1 (Pubitemid 28467031)
32. Luan Z. G., Ma X. C., Guo R. X., Protective effect of ethyl pyruvate on pancreas injury in rats with severe acute pancreatitis. Journal of Surgical Research 2013 181 1 76 84 10.1016/j.jss.2012.05.066
33. Wang H., Su X., Zhao J., Pan H., Mao L., Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF- B pathway after traumatic brain injury in the rat. Mediators of Inflammation 2011 2011 10 2-s2.0-80052669019 10.1155/2011/807142 807142
34. Hu X., Cui B., Zhou X., Xu C., Lu Z., Jiang H., Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Molecular Biology Reports 2012 39 1 227 231 2-s2.0-84855192732 10.1007/s11033-011-0730-5
35. Shen H., Hu X., Liu C., Wang S., Zhang W., Gao H., Stetler R. A., Gao Y., Chen J., Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiology of Disease 2010 37 3 711 722 2-s2.0-75949122041 10.1016/j.nbd.2009.12.010
36. Tsung A., Kaizu T., Nakao A., Shao L., Bucher B., Fink M. P., Murase N., Geller D. A., Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 2005 79 2 196 204 2-s2.0-12744269330 10.1097/01.TP.0000151681.07474.2E
37. Abe Y., Hines I. N., Zibari G., Pavlick K., Gray L., Kitagawa Y., Grisham M. B., Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radical Biology and Medicine 2009 46 1 1 7 2-s2.0-57449098427 10.1016/j.freeradbiomed.2008.09. 029
38. Serracino-Inglott F., Habib N. A., Mathie R. T., Hepatic ischemia-reperfusion injury. American Journal of Surgery 2001 181 2 160 166 2-s2.0-0035043582 10.1016/S0002-9610(00)00573-0 (Pubitemid 32406311)
39. Cai B., Brunner M., Wang H., Wang P., Deitch E. A., Ulloa L., Ethyl pyruvate improves survival in awake hemorrhage. Journal of Molecular Medicine 2009 87 4 423 433 2-s2.0-64149090699 10.1007/s00109-009-0441-8
40. Plotnikov E. Y., Kazachenko A. V., Vyssokikh M. Y., Vasileva A. K., Tcvirkun D. V., Isaev N. K., Kirpatovsky V. I., Zorov D. B., The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney International 2007 72 12 1493 1502 2-s2.0-36649004040 10.1038/sj.ki.5002568 (Pubitemid 350197951)
41. Guo J., Zhang K., Ji Y., Jiang X., Zuo S., Effects of ethyl pyruvate on myocardial apoptosis and expression of Bcl-2 and Bax proteins after ischemia-reperfusion in rats. Journal of Huazhong University of Science and Technology-Medical Science 2008 28 3 281 283 2-s2.0-45749120789 10.1007/s11596-008-0311-6
42. Wang Y., Li B., Sun R., Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochemical Research 2013 38 4 742 752 10.1007/s11064-013-0972-9
43. Bae J. S., Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 2012 35 9 1511 1523 10.1007/s12272-012-0901-5
44. Andrassy M., Volz H. C., Igwe J. C., Funke B., Eichberger S. N., Kaya Z., Buss S., Autschbach F., Pleger S. T., Lukic I. K., Bea F., Hardt S. E., Humpert P. M., Bianchi M. E., Mairbäurl H., Nawroth P. P., Remppis A., Katus H. A., Bierhaus A., High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008 117 25 3216 3226 2-s2.0-51649111202 10.1161/CIRCULATIONAHA.108.769331
45. Chung K.-Y., Park J.-J., Kim Y. S., The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate. Transplantation Proceedings 2008 40 7 2136 2138 2-s2.0-51249100670 10.1016/j.transproceed.2008.06.040
46. Tang D., Kang R., Zeh H. J., Lotze M. T., High-mobility group box 1, oxidative stress, and disease. Antioxidants and Redox Signaling 2011 14 7 1315 1335 2-s2.0-79952366675 10.1089/ars.2010.3356
47. Tang D., Kang R., Livesey K. M., Cheh C.-W., Farkas A., Loughran P., Hoppe G., Bianchi M. E., Tracey K. J., Zeh H. J. III, Lotze M. T., Endogenous HMGB1 regulates autophagy. Journal of Cell Biology 2010 190 5 881 892 2-s2.0-77956386515 10.1083/jcb.200911078
48. Tsung A., Evankovich J., Billiar T., Toll-Like receptors in hepatic ischemia/reperfusion and transplantation. Gastroenterology Research and Practice 2010 2011 8 2-s2.0-77956821916 10.1155/2010/537263 537263
49. Wang H., Li Z.-Y., Wu H.-S., Wang Y., Jiang C.-F., Zheng Q.-C., Zhang J.-X., Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway. Chinese Medical Journal 2007 120 6 509 514 2-s2.0-34047143723 (Pubitemid 46510764)